Evidence map›Paper›PMID 22007239›Full record

ArticleStem cells international2011

Erythroblast enucleation.

Ganesan Keerthivasan, Amittha Wickrema, John D Crispino

Abstract read
In one paragraph

Article in Stem cells international, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Erythroblast enucleation at a glance.Journal of cell science · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Properties and Application of Cell-Free DNA as a Clinical Biomarker.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Nagoya journal of medical science · 2021
    Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ganesan KeerthivasanDivision of Hematology/Oncology, Northwestern University, Chicago, IL 60611, USA.
Amittha Wickrema
John D Crispino

Funding

Role of Survivin in Development of Megakaryocytes and Erythroid CellsR01DK074693 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CRISPINO, JOHN D · 2007 to 2011
$1.6M
NIDDK NIH HHS R01 DK074693
6 · The paper itself

Abstract

Even though the production of orthochromatic erythroblasts can be scaled up to fulfill clinical requirements, enucleation remains one of the critical rate-limiting steps in the production of transfusable red blood cells. Mammalian erythrocytes extrude their nucleus prior to entering circulation, likely to impart flexibility and improve the ability to traverse through capillaries that are half the size of erythrocytes. Recently, there have been many advances in our understanding of the mechanisms underlying mammalian erythrocyte enucleation. This review summarizes these advances, discusses the possible future directions in the field, and evaluates the prospects for improved ex vivo production of red blood cells.

Identifiers

PMID22007239
PMCPMC3189604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.